Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
New England Eye Center, Boston, MA 02111, USA.
The purpose of this study was to synthesize a novel prodrug of ethacrynic acid (ECA) with short chain polyethylene glycols (PEGs) and codrugs of ECA with the beta-adrenergic blocking agent atenolol (ATL) or timolol (TML) to overcome the adverse effects of ECA and to enhance its physicochemical properties.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on